CMV Colitis: A Rare Complication of Azacitidine and Venetoclax Chemotherapy.
Hematol Rep
; 14(3): 213-221, 2022 Jun 23.
Article
en En
| MEDLINE
| ID: mdl-35893153
ABSTRACT
Herein, we present a case of cytomegalovirus (CMV) colitis that occurred after two cycles of azacitidine and venetoclax in a 64-year-old woman affected with acute myeloid leukaemia (AML) secondary to a previous diagnosis of a hypoplastic myelodysplastic syndrome (hypo-MDS). This patient never had detectable CMV viraemia, and there was no evidence of immune deficiency that could justify this opportunistic infection. Additionally, this is most likely the first report describing CMV colitis in a patient treated upfront with azacitidine and venetoclax.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Hematol Rep
Año:
2022
Tipo del documento:
Article